Leonard L. Mazur - Nov 7, 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Nov 7, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 05:00 PM
Previous filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 10.3M Nov 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +600K $0.00 600K Nov 7, 2024 Common Stock 600K $0.38 Direct F1
holding CTXR Warrant to Purchase Common Stock 3.14M Nov 7, 2024 Common Stock 3.14M $1.15 Direct F2
holding CTXR Warrant to Purchase Common Stock 2.23M Nov 7, 2024 Common Stock 2.23M $0.77 Direct F2
holding CTXR Warrant to Purchase Common Stock 1.17M Nov 7, 2024 Common Stock 1.17M $1.42 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 550K Nov 7, 2024 Common Stock 550K $0.70 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 550K Nov 7, 2024 Common Stock 550K $1.25 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 650K Nov 7, 2024 Common Stock 650K $2.04 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Nov 7, 2024 Common Stock 300K $2.00 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 200K Nov 7, 2024 Common Stock 200K $1.01 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 175K Nov 7, 2024 Common Stock 175K $0.67 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 150K Nov 7, 2024 Common Stock 150K $1.62 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 40K Nov 7, 2024 Common Stock 40K $3.45 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 The warrant is fully vested and exercisable immediately.
F3 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F5 The options are vested in full and exercisable immediately.